Tyra Biosciences, Inc. (TYRA)
19.96
-0.43
(-2.11%)
USD |
NASDAQ |
Oct 08, 16:00
19.96
0.00 (0.00%)
After-Hours: 20:00
Tyra Biosciences EPS Diluted (Quarterly) : -0.6904 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.6904 |
| March 31, 2026 | -0.6366 |
| December 31, 2025 | -0.5655 |
| September 30, 2025 | -0.5006 |
| June 30, 2025 | -0.4718 |
| March 31, 2025 | -0.4744 |
| December 31, 2024 | -0.433 |
| September 30, 2024 | -0.4079 |
| June 30, 2024 | -0.3188 |
| March 31, 2024 | -0.3483 |
| December 31, 2023 | -0.5314 |
| September 30, 2023 | -0.4934 |
| June 30, 2023 | -0.3116 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.2802 |
| December 31, 2022 | -0.3055 |
| September 30, 2022 | -0.2978 |
| June 30, 2022 | -0.3613 |
| March 31, 2022 | -0.3568 |
| December 31, 2021 | -0.2396 |
| September 30, 2021 | -0.7249 |
| June 30, 2021 | -0.1296 |
| March 31, 2021 | -0.099 |
| December 31, 2020 | -0.0866 |
| September 30, 2020 | -0.055 |
| June 30, 2020 | -0.0432 |
| March 31, 2020 | -0.0346 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.0464 |
| Anixa Biosciences, Inc. | -0.0762 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -45.56M |
| Total Expenses (Quarterly) | 45.56M |
| Enterprise Value | 868.05M |
| Earnings Yield | -11.99% |
| Normalized Earnings Yield | -11.99 |